Kobo Biotech last traded at ₹4.80 (2026-10-13). Over the past month the stock moved +1.7%, three months the stock moved +33.7%, year the stock moved +113.3%. Its closing range over 52 weeks is ₹2.12 – ₹5.72, with the latest close 16.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1993, Kobo Biotech Ltd is in the pharmaceutical business[1]
Business Overview:[1] KBL manufactures Active Pharmaceutical Ingredients based on Fermentation technology. Its manufacturing facility is located in Solapur, Maharashtra, spread over 21 acres
In the latest quarter (Jun 2024), Kobo Biotech reported sales of ₹0.00 crore and net profit of ₹-1.33 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2024 | 0.00 | -0.34 | – | -1.33 | -0.56 |
| Mar 2024 | 0.00 | -0.25 | – | -1.26 | -0.53 |
| Dec 2023 | 0.00 | -0.20 | – | -1.23 | -0.52 |
| Sep 2023 | 0.00 | -0.20 | – | -1.22 | -0.51 |
| Jun 2023 | 0.00 | -0.23 | – | -1.23 | -0.52 |
| Mar 2023 | 0.00 | -0.79 | – | -1.79 | -0.75 |
| Dec 2022 | 0.00 | -0.17 | – | -1.19 | -0.50 |
| Sep 2022 | 0.00 | -0.21 | – | -1.10 | -0.46 |
| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2025), Kobo Biotech reported sales of ₹0.00 crore and net profit of ₹-5.23 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2025 | 0.00 | -1.24 | – | -5.23 | -2.20 |
| Mar 2024 | 0.00 | -0.88 | – | -4.93 | -2.07 |
| Mar 2023 | 0.00 | -1.50 | – | -5.55 | -2.33 |
| Mar 2022 | 0.00 | -10.51 | – | -15.23 | -6.39 |
| Mar 2021 | 0.00 | -2.79 | – | -19.23 | -8.07 |
| Mar 2020 | 0.00 | -0.69 | – | -21.01 | -8.82 |
| Mar 2019 | 0.00 | -1.72 | – | -24.46 | -10.27 |
| Mar 2018 | 0.00 | -3.02 | – | -23.92 | -10.04 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Kobo Biotech.
Get Free AI Stock Analysis FREE →Broad-Based Technical Strength Lifts Kobo Biotech Ltd to 52-Week High of Rs 4.33
NCLT Approves Beaufond Industries' Resolution Plan for Kobo Biotech Limited - scanx.trade
Kobo Biotech shares were last quoted at ₹4.80 (+4.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Kobo Biotech has a price-to-earnings (P/E) ratio of -1.85 and a price-to-book (P/B) ratio of 0.17. The industry P/E is 54.65.
The 52-week high of Kobo Biotech is ₹9.99 and the 52-week low is ₹1.99.
The market capitalisation of Kobo Biotech is about ₹9.29 crore.
In the latest quarter (Jun 2024), Kobo Biotech reported sales of ₹0.00 crore and net profit of ₹-1.33 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Kobo Biotech has 3-year profit growth of 18.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 44.95% of Kobo Biotech.
Kobo Biotech belongs to the Pharmaceuticals & Drugs sector.